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ABSTRACT  
Purpose: Obese adults with normal glucose tolerance (NGT) but with 1-hour post-load plasma 
glucose (1hPG) ≥155mg/dL are at higher risk of developing type 2 diabetes (T2D) and 
cardiometabolic complications. Little information is available for the pediatric population, where 
recently, a lower cut-off, 132.5 mg/dL, has been suggested as being more sensitive to identify 
subjects at risk of T2D.  
Our aim was to assess whether obese Caucasian youth with 1hPG ≥132.5mg/dL have worse insulin 
sensitivity and secretion and a worse cardiometabolic profile compared to obese youth with 1hPG 
<132.5mg/dL.  
Methods: Medical records of 244 (43% male; age: 11.1±2.7years) overweight/obese children and 
adolescents, who had undergone an oral glucose tolerance test (OGTT), were retrieved. 
Anthropometric and biochemical data were collected from the hard copy archive. Indexes of insulin 
resistance (HOMA-IR), insulin sensitivity (WBISI) and insulin secretion (Insulinogenic Index, 
Disposition Index) were calculated.  
Results: Of the 244 records analyzed, 215 fulfilled criteria for NGT and had complete biochemical 
data. Among NGT patients, 42 (19.5%) showed 1hPG ≥132.5mg/dL (high-NGT), while the 
remaining had 1hPG <132.5mg/dL (low-NGT). The high-NGT group showed a higher male 
prevalence (59.5 vs 37%), lower Disposition Index (0.54[0.39-0.71] vs 0.79[0.47-1.43]) and WBISI 
(0.24[0.18-0.35] vs 0.33[0.23-0.50]) than the low-NGT group. High-NGT subjects also showed a 
trend towards lower HDL-cholesterol and higher TG/HDL ratio (2.13[1.49-3.41] vs 1.66[1.24-
2.49]). 
Conclusions: In overweight/obese NGT Caucasian youth a 1hPG ≥132.5mg/dL was able to identify 
those with impaired insulin sensitivity and secretion and a trend towards a worse cardio-metabolic 
profile, a group likely at risk for future T2D.  
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INTRODUCTION 
Over the last decades, the prevalence of childhood obesity has increased worldwide and this has 
been mirrored by an increasing number of cases of youth-onset type 2 diabetes (T2D), particularly 
in the US (1,2). 
T2D is characterized by reduced insulin sensitivity and secretion (3), and represents a key 
determinant of cardiovascular morbidity and mortality in the adult population (4–6). Recent data 
indicate that especially obese youth with T2D are at increased risk for the development of early 
signs of vascular complications, thus highlighting the importance of preventing this condition (7,8). 
Epidemiological data suggest that about 60% of adults with T2D had either impaired glucose 
tolerance (IGT) or impaired fasting glucose (IFG), two conditions known as pre-diabetes, when 
assessed 5 years prior to diagnosis (9). However, the other 40% of T2D adults had normal glucose 
tolerance (NGT) at baseline, indicating that the use of IFG or IGT categories may overlook a 
considerable proportion of subjects who will develop T2D (9). These observations led to several 
studies investigating alternative models for predicting T2D. Recent reports have identified plasma 
glucose concentration at 1-h ≥155 mg/dl during the oral glucose tolerance test (OGTT) as a strong 
predictor of future risk for T2D in adults of different ethnic backgrounds, independently of glucose 
tolerance status (9–13). In addition, this glucose cutoff identifies subjects with a worse cardio-
metabolic profile, characterized by high blood pressure, dyslipidemia, liver steatosis, early signs of 
atherosclerosis, as well as an increased mortality (14–20). 
Data in the pediatric population are mainly limited to obese American and Hispanic children, where 
the 155 mg/dl cutoff has been related to a worse insulin sensitivity and secretion (21,22). Limited 
information is available for Caucasian children and adolescents. Of interest, a recent study 
performed in obese Caucasian youth suggested that a lower cut-off point of 132.5 mg/dl might 
perform even better in identifying individuals with a high risk for developing T2D among those 
with NGT, having a better sensitivity than the 155 mg/dl cutoff and a similar specificity (23). 
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The aims of the present study were to assess whether NGT obese Caucasian youth with 1-h plasma 
glucose concentration ≥132.5 mg/dl have worse insulin sensitivity and secretion along with a worse 
cardio-metabolic profile compared to obese with 1-h post-load glycemia <132.5 mg/dl, and to 
assess factors associated with high-NGT condition. 
 
METHODS 
Study population 
The study was based on a retrospective review of the hard copy archive of the Pediatric 
Endocrinology Clinic of the Department of Pediatrics (University of Chieti, Italy) for the period 
between November 2011 and February 2016.  
Records of Caucasian children and adolescents (age 4-18 years) affected by overweight (body mass 
index [BMI] ≥ 85th and < 95th percentiles for age and sex) or obesity (BMI ≥ 95th percentile for age 
and sex), who had undergone an OGTT, were selected. 
Anthropometric data (height, weight, BMI, waist circumference, pubertal staging and blood 
pressure measurements) and biochemical data (lipid profile including total cholesterol, high density 
lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and triglycerides) 
were obtained from the hard copy archive.  
None of the patients had chronic diseases (diabetes, thyroid or other endocrine disorders, hereditary 
diseases or systemic inflammation) and none were taking any medication. Data on family history of 
T2D and cardiovascular disease were also retrieved from the archive. 
The study was conducted in compliance with ethical principles based on the Declaration of 
Helsinki. Formal consent for this study was not required, since it was confined to data collected as 
part of a routine assessment of obese children and data were entered into the study database in an 
anonymized and unidentifiable way.  
 
Clinical data 
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All children and adolescents affected by overweight/obesity were seen by the same Pediatric 
Endocrinology team (University of Chieti, Italy), with the supervision of a senior physician, using 
standard methods.  
Height was measured to the nearest 0.1 cm with Harpenden stadiometer (Holtein, Wales, UK). For 
this measurement, patients stood straight, with feet placed together and flat on the ground; heels, 
buttock and scapulae against the vertical backboard; arm loose and relaxed with palms facing 
medially and the head positioned in the Frankfurt plane. Body weight was measured to the nearest 
0.1 kg with a calibrated scale. BMI, used as index of adiposity, was calculated as the weight in 
kilograms divided by the square of the height in meters.  
A flexible tape was used to measure waist circumference to the nearest 1 mm at the mid-point 
between the lower ribs and the pelvic bone. Three waist circumference measurements were taken at 
the midst of each respiratory cycle. 
Height, weight and BMI standard deviation scores (SDS) were calculated based on the age and sex 
reference values for the Italian population (24). The waist to height ratio was also calculated in 
order to have an age- and sex-independent index (25). 
In all patients, pubertal stage was defined on the basis of breast development in girls and genital 
development in boys, based on Tanner’s criteria (26). 
Systolic (SBP) and diastolic (DBP) blood pressure were measured twice, after 10 min rest, using 
standard methods at the non-dominant arm, by using a calibrated sphygmomanometer.  
 
Oral glucose tolerance test 
All study participants had undergone a 2-hour OGTT. All OGTT were performed at the Pediatric 
Endocrine Clinic by the same nurses, using a standard protocol. In details, after an overnight 
fasting, a baseline sample for measurements of glucose and insulin was collected. Afterwards, 
flavored glucose in a dose of 1.75 g/kg body weight (up to a maximum of 75 g) was given orally 
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and blood samples were obtained every 30 min up to 120 min for the measurement of glucose and 
insulin. Samples were transferred to the local laboratory soon after each collection to be processed. 
Glucose tolerance status was classified according to the criteria of the World Health Organization 
(WHO). (27) 
 
Indexes of insulin resistance and secretion 
The Homeostasis Model Assessment of fasting insulin resistance (HOMA-IR), a measure of insulin 
resistance, was computed as follows: HOMA-IR = [fasting insulin (µIU/ml) × fasting glucose 
(mmol/ml)]/22.5 (28) 
The Whole Body Insulin Sensitivity Index (WBISI) was calculated with the formula: WBISI = [10 
000/(fasting glucose × fasting insulin × mean glucose × mean insulin concentration)1/2], where 
mean glucose and mean insulin are the averaged glucose and insulin concentrations; glucose and 
insulin are expressed in mg/dl and µIU/ml, respectively. (29) 
The insulin secretion was estimated by means of the Insulinogenic Index, defined as IGI = [insulin 
(t30) – insulin (t0)/glucose (t30) – glucose (t0)], where glucose is expressed in mg/dl and insulin is 
expressed in µIU/ml and by HOMA-β, computed as follows: HOMA-β = [20 × fasting insulin 
(µIU/ml)/fasting glucose (mmol/l) – 3.5]. (28,30) 
The Disposition Index was calculated with the formula: DI = insulinogenic index/HOMA-IR. (31) 
 
Statistical analysis  
Data were reported as mean ± standard deviation (SD) or median [interquartile range], unless 
otherwise stated. Not normally distributed variables were log-transformed before data analysis.  
Patients with NGT were divided into two groups, based on 1-h plasma glucose, during OGTT: high-
NGT with a 1-h plasma glucose ≥132.5 mg/dl and low-NGT with a plasma glucose <132.5 mg/dl. 
Differences between high-NGT and low-NGT subjects in continuous variables were tested by an 
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unpaired t-test, whereas differences in categorical variables where assessed by χ2 test or Fisher’s 
exact test. Analysis of covariance was applied to adjust for potential confounding factors. 
Logistic regression analysis was performed to assess factors associated with the high-NGT category 
and results are presented as odds ratio [95% confidence interval (C.I.].  
When comparing the main study outcomes (insulin sensitivity/secretion, cardiometabolic 
parameters), multiple testing was controlled for using the false discovery rate (FDR) method, 
using 0.05 as the criterion). All calculations were made with the computer program Statistical 
Package for the Social Science (SPSS) version 22.0 (SPSS Inc., Chicago, IL, USA).  
 
RESULTS 
Description of the sample 
The records of 244 overweight or obese children and adolescents with a mean age of 11.1 ± 2.7 
years (range 4-18) were retrieved and two subjects, who had incomplete biochemical data (insulin 
results), were excluded. Of the remaining 242 patients, 104 were males (43%) and 111 subjects 
(46%) were prepubertal. Ten (4.1%) subjects had IGT, while 17 (7.0%) met the criteria for IFG and 
they were excluded from subsequent analysis. No patient presented with overt diabetes.  
Among 215 subjects with NGT, 42 (19.5%) were classified as high-NGT and 173 (80.5%) as low-
NGT (Figure 1). 
The high-NGT and low-NGT groups were comparable in terms of family history of T2D (42.9% vs 
50.3%) and cardiovascular disease (45.2% vs 56.6%).  
 
Characterization of NGT patients with 1HPG ≥ 132.5 
The high-NGT and low-NGT groups were similar for age, weight, BMI and pubertal stages (Table 
1). For a subgroup of the study population (n 124), waist circumference was also available and there 
were no significant differences between the high-NGT (n 32, 85.8 ± 8.2 cm) and the low-NGT (n 
92, 86.0 ± 12.6 cm) groups (p=0.9) in this parameter or in the waist circumference/height ratio (0.57 
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± 0.06 vs 0.59 ± 0.06, p=0.28). A statistically significant difference was observed for sex 
distribution between the two groups, with a higher prevalence of males in the high-NGT group (p= 
0.009)).  
High-NGT subjects had significantly higher fasting glucose and, as expected, higher 1-h and 2-h 
post-load plasma glucose levels. High-NGT youth had higher 1-h and higher 2-h post-load insulin 
levels (Table 2). 
A significant difference in insulin sensitivity was shown between the two groups by using WBISI, 
with values significantly lower in high-NGT (0.24[0.18-0.35]) than low-NGT youth (0.33[0.23-
0.50]), p=0.003. Similarly, the Insulinogenic Index was significantly reduced in high-NGT subjects 
(1.82[1.24-2.55] vs 2-62[1.46-5.06] p = 0.063). The Disposition Index was significantly lower in 
the high-NGT group (0.54[0.39-0.71] vs 0.33[0.23-0.50], p=0.028 (Figure 2). The above 
comparisons were adjusted for sex, pubertal stages and BMI SDS and for multiple comparisons.  
In contrast, there were no significant differences in HOMA-IR (3.37[2.62-4.66] vs 3.31 [2.23-5.01], 
p=0.58) and HOMA-beta (173.0 [136.8- 243.0] vs 203.7[128.3-321.4], p=0.47) between the high-
NGT and low-NGT groups.  
The high-NGT and low-NGT groups had similar values of total cholesterol, LDL-cholesterol, 
triglycerides, GOT and GPT. In contrast, a trend toward lower HDL-cholesterol the high-NGT 
group (adjusted p= 0.007)) and TG/HDL ratio (higher in the high-NGT group (adjusted p= 0.07)) 
(Table 2). Again these comparisons were adjusted for sex, pubertal stages and BMI SDS and for 
multiple comparisons. No significant differences were observed in SBP and DBP between the two 
groups (Table 2). 
Factors associated with the high-NGT condition were sex (male), insulinogenic index, WBISI and 
baseline glycemia. (Table 3). All but baseline glycemia remained independently associated to the 
high-NGT condition in a multiple regression model.  
 
DISCUSSION  
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This clinical-based study of Caucasian obese youth clearly demonstrated that a considerable 
proportion presented a 1-h plasma glucose greater than 132.5 mg/dL, which was associated not only 
with decreased insulin sensitivity and secretion but also with early signs of cardio-metabolic 
dysfunction, as indicated by a trend towards reduced levels of HDL and increased TG/HDL ratio.  
 
Over the last decades, concomitantly with the epidemics of obesity and its cardio-metabolic 
complications (1,2), there has been growing interest in the identification of early abnormalities in 
glucose metabolism predictive of future risk of T2D (32). In this context, a lot of interest has been 
focused on IGT and IFG, both considered as ’pre-diabetes’ conditions (33), but subsequent studies, 
performed in the adult population, have shown that these categories are not optimal predictor of 
T2D (33,34). This has led to efforts to identify more sensitive and specific markers of T2D risk and 
to the finding that 1-h post-load plasma glucose ≥155 mg/dl during the OGTT is a good predictor 
for the progression to diabetes (9–11,13). Indeed, several lines of evidence have highlighted that 
high-NGT subjects have reduced insulin secretion and increased insulin resistance along with 
higher risk of developing cardiovascular disease and increased mortality rates (10–13,15–19,35).  
In the pediatric population, there are limited data on the value of 1-h post-load glucose, and they are 
data mainly based on studies performed in American and Hispanic obese youth (21,22). In a cross-
sectional study, Tfayli et al (21) showed that, in a group of 113 overweight and obese youth, those 
with a post-load glucose above 155 mg/dl had a reduced disposition index, by approximately 41%, 
compared to their peers with a lower post-load glucose. More recently, in a prospective study, Kim 
et al not only confirmed these findings but also highlighted a predictive role of the 155 mg/dl cutoff 
for β-cell deterioration and progression to prediabetes (22). There is limited information on the 
value of 1-h post-load glucose for Caucasian children and adolescents. The study by Tfayli et al 
(21) included only 65 Caucasian children, whereas more recently, Manco et al (23) performed a 
cross-sectional study in a large Caucasian pediatric population, where it was found that a lower 
cutoff, equal to 132.5 mg/dl, was able to identify NGT children and adolescents at risk of diabetes, 
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with a higher sensitivity and specificity. The latter findings suggest that this lower cutoff might help 
in detecting glucose abnormalities at an earlier stage in youth in order to implement preventative 
strategies.  
In the present study, we found that almost 20% of obese NGT children and adolescents showed a 1-
h post-load glucose ≥132.5 mg/dl, a percentage similar to that reported in adult studies (33,34).  
In addition, we found that high-NGT children and adolescents showed worse glucose and insulin 
profile during the OGTT compared to low-NGT individuals. In line with previous studies, the high 
1-h post-load glucose was associated with reduced insulin sensitivity, as indicated by lower values 
of WBISI. The Disposition Index, which reflects the ability of pancreatic islets to compensate for 
insulin resistance, was around 32% lower in youth with high NGT, suggesting an inadequate β-cell 
compensation, and therefore a very early metabolic marker for an increased risk of future diabetes 
development (3).  
Previous studies have shown a worse cardio-metabolic profile associated with high 1-h plasma 
glucose. In particular, adults with NGT and 1-h glucose above 155 mg/dl showed high blood 
pressure and lipid levels, and increased prevalence of liver steatosis and increased inflammatory 
markers along with subclinical signs of cardiovascular disease, such as increased intima-media 
thickness, vascular stiffness and left ventricular hypertrophy (15–19). More recently, a large 
prospective study in adults has also highlighted an increased mortality risk associated with high 1-h 
glucose levels (35). 
In the present study, we could not detect any association between 1-h plasma glucose and classic 
feature of metabolic syndrome, in contrast to adult studies. However, it needs to be highlighted that, 
the high-NGT group showed a trend towards decreased HDL levels a higher TG/HDL ratio. The 
latter is a recently emerged marker of cardiovascular risk and previous studies have shown that, in 
obese adults and children, the TG/HDL-C ratio is strongly associated with insulin resistance and 
early signs of cardiovascular complications, such as increased intima-media thickness (36,37). 
Therefore, in our young study population the TG/HDL ratio might represents an early cardio-
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metabolic abnormality related to the high post-load glucose This finding adds to the previous 
association between 1-h plasma glucose above 132.5 mg/dL and risk of T2Din the pediatric 
population (23), by suggesting a wider link with cardio-metabolic complications. 
 
An interesting finding of the present study was that boys were at higher risk of having 1-h plasma 
glucose above 132.5 mg/dl, even though girls were more represented in our study population. This 
is in line with findings from adult studies, where a higher percentage of males was detected among 
the high-NGT category (18,38). The increased metabolic risk for boys might also be related to 
intrinsic characteristics of our Caucasian population. This is also supported by findings from 
another study from our group, where even the genetic risk of having a higher BMI was more 
evident in boys than in girls (39). 
Some limitations of the present study need to be acknowledged. In particular, the retrospective 
study design limited the clinical/biochemical data we could analyze. However, all obese children 
and adolescents included in the study were assessed in the same center using standardized 
techniques and that gives validity to the study findings. Another study limitation is related to the 
assessment of a single OGTT, given the known variable reproducibility of this test. However, the 
study reflects what generally happens in the clinical setting, where the OGTT is a test, which can be 
easily performed, but it is repeated only when abnormal findings are detected. The findings of this 
study highlight how an OGTT could be a useful means in the clinical setting and not only in the 
research setting to identify youth at potential increased risk of T2D. 
The results of the present study emphasize the importance of an early diagnosis of prediabetes, 
which is related to the possibility of an early lifestyle intervention. Indeed, several lines of evidence 
have highlighted that lifestyle interventions prevent or delay the progression from IGT (or IFG) 
condition to that of overt diabetes. However, it is unknown whether high-NGT youth may benefit 
from lifestyle intervention similarly to IGT individuals. Unfortunately, the respective nature of this 
study design did not allow the estimation of the predictive role of the specific 1-h cutoff used. 
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Therefore, longitudinal studies are needed to investigate whether or not this early impairment in 
insulin sensitivity and secretion will translate into higher rates of T2D in the future. 
 
In conclusion, the present study suggests that, at least in the clinical setting, a high 1-h post-load 
glycemia might be an early metabolic signal for an enhanced risk of developing diabetes. Although 
this finding needs to be confirmed by future studies, obese children with 1-h plasma glucose 
response during the OGTT exceeding 132.5 mg/dL may require more vigilant follow-up and 
lifestyle recommendation in order to avoid further weight gain and promote weight lost need to be 
strongly encouraged. 
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Table 1. General characteristics of low-NGT and high-NGT youth 
 
Variables Low-NGT High-NGT p value 
N (%) 173 (80.5%) 42 (19.5%)   
sex (male/female) 64 (37%)/109 (63%) 25 (59.5%)/17 
(40.5%) 
0.009 
Prepubertal/pubertal/postpubertal 92 (53.2%)/40 
(23.1%)/41 (23.7%) 
19 (45.2%)/14 
(33.3%)/9 (21.3%) 
0.68 
Age (years) 10.8 ± 2.7 11.0 ± 2.7 0.59 
    
Weight (SDS) 2.21 ± 0.72 2.15 ± 0.78 0.66 
    
Height (SDS) 0.66 ± 1.06 0.64 ± 1.33 0.92 
    
BMI (SDS) 2.24 ± 0.50 2.24 ± 0.55 0.98 
Overweight/Obese 22 (12.7%)/151 (87.3%) 5 (11.9%)/37 (88.1%) 0.56 
Data are expressed as mean ± SD.  
NGT: normal glucose tolerance. SDS: standard deviation score. BMI: body mass index.  
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Table 2. Glucose metabolism data and cardiometabolic profile in the study population. 
Variables Low-NGT High-NGT p value* Benjamini-
Hochberg 
P-value 
 
HbA1c (mmol) 
HbA1c (%) 
35.2 ± 3.71 
5.37 ± 0.34 
36.6 ± 3.75 
5.49 ± 0.34 
 
0.06 
 
C-peptide 2.37 ± 0.98 2.53 ± 1.04 0.88  
Glucose T0 (mg/dl) 90.2 ± 7.30 92.9 ± 5.9 0.25  
Glucose 60’ (mg/dl) 104.9 ± 16.5  143.0 ± 18.7 <0.001 <0.001 
Glucose 120’ (mg/dl) 101.9 ± 14.5 114.4 ± 13.9 <0.001 <0.001 
Insulin T0  15.0[9.92-22.5] 14.5[10.7-20.4] 0.77  
Insulin 60’ 61.8[37.0-110.0] 120.9[70.5-158.9] <0.001 <0.001 
Insulin 120’ 61.0[33.9-94.1] 94.5[56.7-143.6] 0.007 0.029 
Total cholesterol  162.4 ± 30.8 161.3 ± 34.0 0.96  
HDL-cholesterol 48.0 ± 9.93 43.7 ± 9.38 0.026 0.07 
LDL-cholesterol 94.3 ± 26.4 95.8 ± 30.0 0.67  
Triglycerides 
(mg/dl) 
80.0[63.0-108.0] 94.5[69.7-124.7] 0.098  
Tg/HDL 1.66[1.24-2.49] 2.13[1.49-3.41] 0.029 0.07 
GOT (U/L) 29.3 ± 9.6 30.5 ± 10.1 0.78  
GPT (U/L) 34.8 ± 17.9 36.7 ± 18.0 0.88  
SBP 115.2 ± 14.8 114.2 ± 13.1 0.28  
SBP SDS 0.97 ± 1.22 0.76 ± 1.02 0.22  
DBP 69.2 ± 8.90 69.2 ± 8.85 0.81  
DBP SDS  0.67 ± 0.74 0.64 ± 0.73 0.89  
Data are expressed as mean ± SD or median[interquartile range].  
DBP: diastolic blood pressure; GOT: glutamic-oxaloacetic transaminase; GPT: glutamic-pyruvic 
transaminase; HDL: high-density lipoprotein; HbA1c: glycosylated hemoglobin; LDL: low-density 
lipoprotein; NGT: normal glucose tolerance;  Tg: triglycerides; SBP: systolic blood pressure; SDS: 
standard deviation score;  
 
*p values adjusted for sex, pubertal stage and BMI SDS 
 
 
 
 
 
20 
 
 
 
Table 3. Factors associated with high-NGT in the study population 
 Odds ratio 
[95%C.I.] 
p 
value 
Odds ratio  
[95% C.I.] 
p 
value 
Age 1.036 [0.913-1.174] 0.59   
Sex (male) 2.505 [1.257-4.989] 0.009 2.628 [1.197-5.767] 0.016 
Pubertal stage 1.088 [0.723-1.626] 0.69   
BMI SDS 1.010 [0.523-1.950] 0.98   
WBISI (log) 0.199 [0.051-0.776] 0.020 0.026 [0.004-0.160] <0.001 
Insulinogenic index (log) 0.372 [0.156-0.885] 0.025 0.092 [0.024-0.35] <0.001 
Glycaemia T0 1.065 [1.007-1.127] 0.028 1.053 [0.988-1.1.21] 0.116 
Insulin T0 (log) 1.063 [0.292-3.867] 0.926   
Data are expressed as odds ratios [95% confidence intervals] and associated p values.  
WBISI: Whole Body Insulin Sensitivity Index; Wht: waist circumference height ratio 
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Figure legend 
Figure 1. Study cohort Flowchart 
Figure 2. Indexes of insulin resistance and secretion: low-NGT vs high-NGT 
Data are on the log10 scale and are expressed as means, 95% confidence interval. DI: disposition 
index; NGT: normal glucose tolerance; WBISI: Whole Body Insulin Sensitivity Index. 
Benjamini-Hochberg P-value are reported 
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial Study group 
N = 244 
(43% male;  
mean age: 11.1 ± 2.7 yrs) 
) 
Excluded for incomplete 
biochemical data  
N= 2 (0.8%) 
 
NGT 
N = 215 (88.1%) 
(41.4% male, mean 
age: 10.9 ± 2.8 yrs) 
IGT 
N = 10 (4.1%) 
(60% male; mean 
age: 13.8 ± 1.7 yrs) 
IFG 
N = 17 (7.0%) 
(50% male; mean 
age: 12.6 ± 2.7 yrs) 
Low-NGT 
N=173 (80.5%) 
(37% male; mean 
age: 10.8 ± 2.7 yrs) 
 
High-NGT 
N = 42 (19.5%) 
(59.5% male; mean 
age: 11.0 ± 2.7 yrs) 
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Figure 2.  
 
 
P=0.00329 
P=0.063 
P=0.028 
